| Comparison of the results of exercise TI-201 spect and Tc-99m tetrofosmin spect in patients with normal coronaries and left bundle branch block | Ahmet TEMİZHAN,İzzet TANDOĞAN,Ertan YETKİN,Seniha NALDÖKEN,Ahmet ÇAMSARI,Funda DEREAĞZI,Ali ŞAŞMAZ | 410–414 |
| Assessment of aortic regurgitation and delayed relaxation | GÜLİZAR SÖKMEN,Bayram KORKUT,Kurtuluş ÖZDEMİR,Mehmet TOKAÇ,ABDULLAH SÖKMEN,Hasan GÖK | 415–425 |
| The importance of the P wave for the assessment of atrial fibrilation recurrences after successful cardioversion in patients with organic heart disease and chronic atrial fibrilation | Bülent B. ALTUNKESER,Kurtuluş ÖZDEMİR,Hasan GÖK,Ahmet TEMİZHAN,Turgut KARABAĞ | 426–429 |
| Hematological parameters in patient with atrial fibrilation | Merih BAYKAN,Şükrü ÇELİK,ismet durmuş,Remzi YILMAZ,Şahin KAPLAN,Cevdet ERDÖL,Ercüment OVALI | 430–433 |
| The influence of nocturnal blood pressure change (Dipping) on QT dispersion in essential hypertensive patients | ERTAN VURUŞKAN,İrem DİNÇER,Yusuf ATMACA,Mustafa KILIÇAP,Çetin EROL,Nail ÇAĞLAR,Derviş ORAL | 434–437 |
| The safety of beta-blocker treatment for coronary artery disease patients with known chronic obstructive pulmonary disease | Ahmet ÇAMSARI,Candan AVAN,Deniz KAYA,Mehmet ALKAN,Zehra GÖLBAŞI,Hülya ÇİÇEKÇİOĞLU,Sinan AYDOĞDU | 438–442 |
| The safety of beta blocker therapy in class 4 congestive heart failure patients followed in an outpatient basis | Deniz KAYA,Candan AVAN,Ahmet ÇAMSARI,Hakan BAYOL,Mehmet ALKAN,Sinan AYDOĞDU | 443–445 |
| Prediction of the lesion localization on left anterior descending artery in acute anterior myocardial infarction by electrocardiographic findings at the presentation | Altunbaş Ayşegül IRMAK,Telat KELEŞ,Zekeriya KAPTAN,Hakan ERASLAN,M. Koray GÜRSEL,Sinan AYDOĞDU | 446–449 |
| Is factor V Leiden mutation a risk factor for acute miyocardial infarction in young patients with angiographically normal coronary arteries? | Şükrü ÇELİK,Merih BAYKAN,Fahri UÇAR,Remzi YILMAZ,İsmet DURMUŞ,Cevdet ERDÖL,Ercüment OVALI | 450–453 |
| Atorvastatin therapy in non-insulin dependant diabetic patients with combined hyperlipidemia |